Lansoprazol Gastroliber Pentafarma (Lansoprazole)

Lansoprazole blocks the H+/K+ ATPase enzyme, also known as the gastric proton pump, on the surface of parietal cells. This inhibition stops the final step of acid production, leading to a sustained reduction in gastric acid secretion and an increase in stomach pH.

The specific dose and dosing schedule are determined by the prescribing clinician based on the patient’s condition, severity, and response to therapy. Patients should follow the prescriber’s instructions and not alter the dose without medical advice.

Safety information for pregnancy and lactation is limited. The prescriber should evaluate the potential benefits against any possible risks to the fetus or infant before initiating therapy. Women who are pregnant, planning pregnancy, or breastfeeding should discuss use with their healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Lansoprazole belongs to the proton pump inhibitor class, which provides more potent and longer‑lasting acid suppression than H2‑receptor antagonists such as ranitidine. Compared with other PPIs, its efficacy is similar, though individual response and drug‑interaction profiles may differ.

Store the product at room temperature, below 25 °C, in the original packaging. Keep it away from moisture, direct sunlight, and excessive heat to maintain stability and potency.

The medication is taken orally, usually as a whole tablet swallowed with water. It is commonly administered before a meal, often in the morning, but patients should follow the specific timing advised by their prescriber.

Serious risks, though rare, include severe allergic reactions (anaphylaxis), low magnesium levels that can cause muscle cramps or cardiac arrhythmias, and Clostridioides difficile infection leading to severe diarrhea. Patients should seek immediate medical attention if they experience any of these symptoms.

Individuals with a known hypersensitivity to lansoprazole or any other component of the formulation should avoid this product. Caution is also advised for patients with severe liver disease, certain drug interactions, or those who have experienced previous adverse reactions to proton pump inhibitors.